![]() |
|||
|
|
|
|
| UPDATE: February 2008 | MW: 371.42 | MF: C16H18N3O4S•Na |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
N/R
|
N/R
|
N/R
|
N/R
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | mouse
lowest published toxic dose: 17.12 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.)
|
BPBLEO 29,1559,2006
|
intraperitoneal | mouse
lethal dose (50 percent kill): 5,700 mg/kg
|
N/R
|
TXAPA9 18,185,1971
|
intraperitoneal | rat
lethal dose (50 percent kill): 7,400 mg/kg
|
N/R
|
TXAPA9 18,185,1971
|
intravenous | mouse
lowest published lethal dose: 2,657 mg/kg
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Respiratory depression
BJPCAL 18,356,1962
|
oral | mouse
lethal dose (50 percent kill): >5,314 mg/kg
|
N/R
|
BJPCAL 18,356,1962
|
oral | rat
lethal dose (50 percent kill): >5,314 mg/kg
|
N/R
|
BJPCAL 18,356,1962
|
oral | woman
lowest published toxic dose: 100 mg/kg/5 day
|
Gastrointestinal: Hypermotility, diarrhea | Gastrointestinal: Other changes
LANCAO 2,707,1978
|
subcutaneous | mouse
lethal dose (50 percent kill): >5,314 mg/kg
|
N/R
|
BJPCAL 18,356,1962
|
subcutaneous | rat
lethal dose (50 percent kill): >5,314 mg/kg
|
N/R
|
BJPCAL 18,356,1962
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | rat
lowest published toxic dose: 210 mg/kg/7 day- intermittent
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
INJPD2 18,110,1986
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Limited Evidence
|
IMEMDT 50,153,1990
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Inadequate Evidence
|
IMEMDT 50,153,1990
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 3
|
IMEMDT 50,153,1990
|
TOXICOLOGY REVIEW
|
|
INTEAG 15,7,1974
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X3564 |
Number of Industries 2; Total Number of Facilities 549; Number of Occupations 8; Total Number of Employees Exposed 23,006; Total Number of Female Employees Exposed 18,439 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
BJPCAL
|
British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For
publisher information, see BJPCBM.
|
BPBLEO
|
Biological and Pharmaceutical Bulletin. (Pharmaceutical Society of Japan, 2-12-15-201 Shibuya
Shibuya-ku, Tokyo 150, Japan) V.16- 1993-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
INJPD2
|
Indian Journal of Pharmacology. (Dept. of Pharmacology, Baranas Hindu Univ., Varanasi 221
005, India) V.1- 1968(?)-
|
INTEAG
|
Internist. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094)
V.1- 1960-
|
LANCAO
|
Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823-
|
TXAPA9
|
Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1- 1959-
|
| |